766 related articles for article (PubMed ID: 4031069)
1. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.
Salen G; Shefer S; Tint GS; Nicolau G; Dayal B; Batta AK
J Clin Invest; 1985 Aug; 76(2):744-51. PubMed ID: 4031069
[TBL] [Abstract][Full Text] [Related]
2. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Cheng FW; Dayal B; Batta AK; Tint GS
J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
[TBL] [Abstract][Full Text] [Related]
3. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
Salen G; Shefer S; Tint GS
Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
[TBL] [Abstract][Full Text] [Related]
4. Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
J Biol Chem; 2001 Sep; 276(37):34579-85. PubMed ID: 11454857
[TBL] [Abstract][Full Text] [Related]
5. Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid.
Oftebro H; Björkhem I; Skrede S; Schreiner A; Pederson JI
J Clin Invest; 1980 Jun; 65(6):1418-30. PubMed ID: 7410549
[TBL] [Abstract][Full Text] [Related]
6. Cerebrotendinous xanthomatosis: defective liver mitochondrial hydroxylation of chenodeoxycholic acid precursors.
Oftebro H; Björkhem I; Størmer FC; Pedersen JI
J Lipid Res; 1981 May; 22(4):632-40. PubMed ID: 6792308
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of chenodeoxycholic acid in man: stereospecific side-chain hydroxylations of 5beta-cholestane-3alpha,7alpha-diol.
Shefer S; Cheng FW; Batta AK; Dayal B; Tint GS; Salen G
J Clin Invest; 1978 Sep; 62(3):539-45. PubMed ID: 690184
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of potential precursors of chenodeoxycholic acid in cerebrotendinous xanthomatosis (CTX).
Salen G; Shefer S; Mosbach EH; Hauser S; Cohen BI; Nicolau G
J Lipid Res; 1979 Jan; 20(1):22-30. PubMed ID: 438653
[TBL] [Abstract][Full Text] [Related]
9. A 25-hydroxylation pathway of cholic acid biosynthesis in man and rat.
Shefer S; Cheng FW; Dayal B; Hauser S; Tint GS; Salen G; Mosbach EH
J Clin Invest; 1976 Apr; 57(4):897-903. PubMed ID: 181403
[TBL] [Abstract][Full Text] [Related]
10. Anomalous enantioselectivity in the sharpless asymmetric dihydroxylation reaction of 24-nor-5beta-cholest-23-ene-3alpha,7alpha,12alpha-triol: synthesis of substrates for studies of cholesterol side-chain oxidation.
Ertel NH; Dayal B; Rao K; Salen G
Lipids; 1999 Apr; 34(4):395-405. PubMed ID: 10443973
[TBL] [Abstract][Full Text] [Related]
11. Bile acid synthesis in HepG2 cells: effect of cyclosporin.
Levy J; Budai K; Javitt NB
J Lipid Res; 1994 Oct; 35(10):1795-800. PubMed ID: 7852856
[TBL] [Abstract][Full Text] [Related]
12. Bile alcohol metabolism in man. Conversion of 5beta-cholestane-3alpha, 7alpha,12alpha, 25-tetrol to cholic acid.
Salen G; Shefer S; Setoguchi T; Mosbach EH
J Clin Invest; 1975 Jul; 56(1):226-31. PubMed ID: 1141434
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of bile alcohols in the perfused rabbit liver.
Cohen BI; Kuramoto T; Rothschild MA; Mosbach EH
J Biol Chem; 1976 May; 251(9):2709-15. PubMed ID: 1262339
[TBL] [Abstract][Full Text] [Related]
14. Effect of biliary obstruction on 26-hydroxylation of C27-steroids in bile acid synthesis.
Gustafsson J
J Lipid Res; 1978 Feb; 19(2):237-43. PubMed ID: 632686
[TBL] [Abstract][Full Text] [Related]
15. Regulation of 25- and 27-hydroxylation side chain cleavage pathways for cholic acid biosynthesis in humans, rabbits, and mice. Assay of enzyme activities by high-resolution gas chromatography;-mass spectrometry.
Honda A; Salen G; Shefer S; Matsuzaki Y; Xu G; Batta AK; Tint GS; Tanaka N
J Lipid Res; 2000 Mar; 41(3):442-51. PubMed ID: 10706592
[TBL] [Abstract][Full Text] [Related]
16. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
J Lipid Res; 2001 Feb; 42(2):291-300. PubMed ID: 11181760
[TBL] [Abstract][Full Text] [Related]
17. Role of the 26-hydroxylase in the biosynthesis of bile acids in the normal state and in cerebrotendinous xanthomatosis. An in vivo study.
Björkhem I; Fausa O; Hopen G; Oftebro H; Pedersen JI; Skrede S
J Clin Invest; 1983 Jan; 71(1):142-8. PubMed ID: 6848555
[TBL] [Abstract][Full Text] [Related]
18. Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis.
Koopman BJ; Wolthers BG; van der Molen JC; Waterreus RJ
Clin Chim Acta; 1985 Oct; 152(1-2):115-22. PubMed ID: 4053393
[TBL] [Abstract][Full Text] [Related]
19. Quantitative aspects of the conversion of 5 beta-cholestane intermediates to bile acids in man.
Schwartz CC; Cohen BI; Vlahcevic ZR; Gregory DH; Halloran LG; Kuramoto T; Mosbach EH; Swell L
J Biol Chem; 1976 Oct; 251(20):6308-14. PubMed ID: 185209
[TBL] [Abstract][Full Text] [Related]
20. Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5beta-cholestane-3alpha,7alpha,12alpha-triol in human liver microsomes.
Furster C; Wikvall K
Biochim Biophys Acta; 1999 Jan; 1437(1):46-52. PubMed ID: 9931427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
